Skip to content

Investigation of the COMT Val158Met variant association with age of onset of psychosis, adjusting for cannabis use

Rohit Jaibhagwan Lodhi, Yabing Wang, David Rossolatos, Georgina MacIntyre, Alexandra Bowker, Candice E. Crocker, Hongyan Ren, Aleksandra Dimitrijević, Darren A. Bugbee, Alexandra Loverock, Brett Majeau, Sudhakar Sivapalan, Virginia M. Newton, Philip G. Tibbo, Scot E. Purdon, Katherine Jean Aitchison

Brain and Behavior October 6, 2017 DOI: 10.1002/brb3.850 (opens in new tab)

The journal has published a correction to this paper. Read the correction (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Observational cohort Peer reviewed
Sample size 169
Population Canadian Caucasian subjects with psychosis
Measures Structured Clinical Interview for DSM-IV, self-report computerized questionnaire, SNaPshot and TaqMan assays
Topics Cannabis
Citations 12
Key findings Among participants who used cannabis before age 20, the COMT rs4680 genotype showed a trend-level association with age of psychosis onset, with median onset ages of 19.37, 20.95, and 21.24 years for Val/Val, Val/Met, and Met/Met, respectively (log-rank p = .051). The authors indicate that further investigation of this association is needed.

Abstract

Abstract Objective COMT rs4680 (Val158Met) genotype moderates the effect of cannabis on the age of onset of psychosis (AoP). We investigated the association between rs4680 and AoP, after adjusting for relevant covariates, in a Canadian Caucasian sample.

Methods: One hundred and sixty‐nine subjects with psychosis were recruited. AoP, defined as age of DSM‐IV diagnosis was established using the Structured Clinical Interview for DSM‐IV. Cannabis use data were collected using a self‐report computerized questionnaire. DNA was extracted from saliva and genotyping of the COMT Val158Met polymorphism was done by SNaPshot and TaqMan assays. Logistic regression and Kaplan–Meier analysis results are reported.

Results: In those who had used cannabis before 20 years of age, rs4680 had a trend level effect on AoP (median AoP: Val/Val < Val/Met < Met/Met 19.37, 20.95, 21.24 years, respectively; log‐rank test p = .051).

Conclusion: Our data are indicative of the need to further investigate the association between the COMT rs4680 variant and AoP in the context of adolescent cannabis use.

Comparable studies

Other observational and cohort studies on cannabis, most cited first.

Study Year Design Participants
High-potency cannabis and the risk of psychosis People with first episode of psychosis and healthy controls from the local population 2009 Case-control study n = 454
Ayahuasca-Assisted Therapy for Addiction: Results from a Preliminary Observational Study in Canada Rural aboriginal population 2013 Observational study
Impaired cognitive performance in drug free users of recreational ecstasy (MDMA) Otherwise healthy young people 2000 Observational
Continued cannabis use and risk of incidence and persistence of psychotic symptoms: 10 year follow-up cohort study Individuals from the general population in Germany aged 14-24 at baseline 2011 Observational cohort n = 1,923
Cannabis-induced psychosis and subsequent schizophrenia-spectrum disorders: follow-up study of 535 incident cases Patients treated for cannabis-induced psychotic symptoms in Denmark between 1994 and... 2005 Observational cohort n = 535

Citations in the library

Explore topics